Whiterabbit.ai

Whiterabbit.ai

AI-driven breast health diagnostics platform

Overview

Whiterabbit.ai builds AI-powered software for early disease detection in breast health. Its tools support radiology centers, clinicians, and payors by improving diagnostic accuracy, compliance, and operational efficiency, while also helping to increase revenue. The core product suite analyzes medical imaging data and related information to assist radiologists with detection and decision-making, streamline workflows, and ensure adherence to regulatory and quality standards. The company trains and validates its software on one of the world’s largest radiology datasets, aiming for reliable performance in real-world clinical settings. Revenue comes from software licensing and service fees paid by healthcare providers. The overarching goal is to make late-stage diseases rare by enabling earlier detection and timely intervention.

About Whiterabbit.ai

Simplify's Rating
Why Whiterabbit.ai is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

AI & Machine Learning

Healthcare

Company Size

11-50

Company Stage

N/A

Total Funding

N/A

Headquarters

Santa Clara, California

Founded

2017

Get referred to Whiterabbit.ai

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ACR AI-LAB availability broadens distribution to radiology practices using existing workflows.
  • 2024 RadNet partnership directly tackles mammography compliance and diagnostic revenue for providers.
  • 2026 job postings for a research intern show continued model development and hiring activity.

What critics are saying

  • Only one recent open role signals a thin team and limited execution bandwidth.
  • PitchBook shows just $19.5 million Series C in February 2024, constraining scale-up.
  • Radiology AI incumbents and ACR-connected models can commoditize breast-density software quickly.

What makes Whiterabbit.ai unique

  • WRDensity is FDA-cleared and listed on ACRconnect, ahead of investigational rivals.
  • Whiterabbit.ai trained WRDensity on 600,000+ images from Mallinckrodt Institute of Radiology.
  • WRRisk plus WRDensity targets screening workflow, density assessment, and breast-cancer risk in one platform.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

-1%

2 year growth

-1%
Newswise
Apr 10th, 2024
AI-assisted breast-cancer screening may reduce unnecessary testing

Wahl previously collaborated with Whiterabbit.ai on an algorithm to help radiologists judge breast density on mammograms to identify people who could benefit from additional or alternative screening.

AuntMinnie.com
Nov 7th, 2023
Whiterabbit Collaborates with ACR for democratized AI access

AI technology developer Whiterabbit.ai is collaborating with the American College of Radiology (ACR) Data Science Institute to make its AI-driven breast density software, WRDensity, available on the ACR's AI-LAB platform.

Greensands Equity
Oct 10th, 2023
Investments | Green Sands Equity

Lyft is an American ridesharing company based in San Francisco, California, operating in 644 cities in the United States and 12 cities in Canada.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Whiterabbit.ai right now.

Find jobs on Simplify and start your career today

We update Whiterabbit.ai's jobs every few hours, so check again soon! Browse all jobs →